HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.

Abstract
The expression of chemokines and their receptors is thought to contribute to leukocyte infiltration and progressive renal fibrosis after unilateral ureter obstruction (UUO). We hypothesized that blocking the chemokine receptor CCR1 using the nonpeptide antagonist BX471 could reduce leukocyte infiltration and renal fibrosis after UUO. UUO kidneys from BX471-treated mice (day 0-10 and day 6-10) revealed a 40-60% reduction of interstitial macrophage and lymphocyte infiltrate compared with controls. Treated mice also showed a marked reduction of CCR1 and CCR5 mRNA levels, and FACS analysis showed a comparable reduction of CD8+/CCR5+ T cells. Markers of renal fibrosis, such as interstitial fibroblasts, interstitial volume, mRNA and protein expression for collagen I, were all significantly reduced by BX471-treatment compared with vehicle controls. By contrast treatment was ineffective when the drug was supplied only from days 0 to 5. In summary, blockade of CCR1 substantially reduces cell accumulation and renal fibrosis after UUO. Most interestingly, late onset of treatment is also effective. We therefore conclude that CCR1 blockade may represent a new therapeutic strategy for reducing cellular infiltration and renal fibrosis as major factors in the progression to end-stage renal failure.
AuthorsHans-Joachim Anders, Volker Vielhauer, Michael Frink, Yvonne Linde, Clemens D Cohen, Simone M Blattner, Matthias Kretzler, Frank Strutz, Matthias Mack, Hermann-Josef Gröne, James Onuffer, Richard Horuk, Peter J Nelson, Detlef Schlöndorff
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 109 Issue 2 Pg. 251-9 (Jan 2002) ISSN: 0021-9738 [Print] United States
PMID11805137 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CCR1 protein, human
  • Ccr1 protein, mouse
  • Phenylurea Compounds
  • Piperidines
  • Receptors, CCR1
  • Receptors, Chemokine
  • BX 471
  • Calcium
Topics
  • Animals
  • Calcium (metabolism)
  • Cell Line
  • Cell Movement (drug effects)
  • Cytosol (metabolism)
  • Fibrosis (drug therapy, etiology, metabolism)
  • Humans
  • Kidney Diseases (drug therapy, etiology, metabolism)
  • Kidney Tubules (injuries)
  • Leukocytes (drug effects, physiology)
  • Ligation (adverse effects)
  • Mice
  • Mice, Inbred C57BL
  • Phenylurea Compounds (pharmacokinetics, pharmacology)
  • Piperidines (pharmacokinetics, pharmacology)
  • Protein Binding
  • Receptors, CCR1
  • Receptors, Chemokine (antagonists & inhibitors, genetics, metabolism)
  • Ureter (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: